Skip to main content
. 2022 Jan 20;25(1):66–70. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2021.101.50

图 2.

图 2

不同治疗时期的图像。A:治疗前;B:2个周期吉西他滨+顺铂化疗后;C: 2个周期依托泊苷+卡铂化疗后;D:2个周期安罗替尼+卡瑞丽珠单抗治疗后;E:4个周期安罗替尼+卡瑞丽珠单抗治疗后。

Images of different treatment periods. A: Prior treatment; B: After 2 cycles of gemcitabine+cisplatin; C: After 2 cycles of etoposide+carboplatin; D: After 2 cycles of anlotinib+carrizumab; E: After 4 cycles of anlotinib+carrizumab.